Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis.
Nicolás Lundahl Ciano-PetersenMélisse RobertSergio Muñiz-CastrilloValentin WucherAmna KlichAlberto VogrigMacarena VillagránAntonio FarinaDavid GoncalvesGeraldine PicardVéronique RogemondBastien JoubertBegoña OliverPedro Jesús Serrano-CastroDelphine Maucort-BoulchJerome HonnoratPublished in: Neurology(R) neuroimmunology & neuroinflammation (2023)
In this study, patients with persistent CSF NMDAR-Abs at 12 months were more likely to have subsequent relapses and a poor long-term outcome. However, these findings should be interpreted with caution because of the variability in the time of sampling of this study. Future prospective studies are required to validate these results in larger cohorts.
Keyphrases